Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's
Cell Death and Differentiation
|January 10, 2004
Summary
Caspase-2 cleaves mutant huntingtin, initiating cell death in Huntington's disease (HD) neurons. This finding highlights caspase-2 as a potential therapeutic target for this progressive neurodegenerative disorder.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Huntington's disease (HD) is a neurodegenerative disorder characterized by selective neuronal loss in the striatum and cortex.
- The precise molecular mechanisms driving selective neuronal cell death in HD remain poorly understood.
- Proteolytic processing of mutant huntingtin (Htt) is implicated in HD pathogenesis, but the specific caspases involved are unknown.
Purpose of the Study:
- To investigate the role of specific caspases in mutant Htt-induced cell death.
- To determine if caspase cleavage of Htt in vivo correlates with selective neuronal cell loss in HD.
- To identify the specific caspase responsible for cleaving Htt at residue 552.
Main Methods:
- In vitro assays to assess caspase cleavage of Htt.
- Analysis of Htt-caspase interactions and apoptosome complex formation.
- Cell death assays using primary striatal cells from HD transgenic mice (YAC72).
- Histological analysis of human post-mortem brain tissue and YAC72 mouse brains.
- Measurement of caspase activation and brain-derived neurotrophic factor (BDNF) levels.
Main Results:
- Caspase-2 was identified as the specific enzyme cleaving Htt at amino acid 552.
- Mutant Htt recruits caspase-2 into an apoptosome-like complex in a polyglutamine repeat-length-dependent manner.
- Caspase-2 is required for the death of primary striatal cells from YAC72 mice.
- Inhibition of caspase-2, -7, and -6 reduced YAC72 cell death, while inhibition of caspase-3, -8, and -9 had no effect.
- Activated caspases and enhanced caspase-2 immunoreactivity were observed in striatal and cortical neurons of HD patients and YAC72 mice.
- Upregulation of caspase-2 correlated with decreased BDNF levels in early-stage YAC72 mice.
Conclusions:
- Caspase-2 plays a critical role in the selective neuronal cell death observed in Huntington's disease.
- The interaction between mutant Htt and caspase-2 is an early event in HD pathogenesis.
- Targeting caspase-2 may offer a novel therapeutic strategy for Huntington's disease.
Related Concept Videos
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...